These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 28486001)
61. [The rise of resistant gram-negative bacteria]. Kuijper EJ; van Dissel JT Ned Tijdschr Geneeskd; 2010; 154(45):A2868. PubMed ID: 21118590 [TBL] [Abstract][Full Text] [Related]
62. Will new antimicrobials overcome resistance among Gram-negatives? Bassetti M; Ginocchio F; Mikulska M; Taramasso L; Giacobbe DR Expert Rev Anti Infect Ther; 2011 Oct; 9(10):909-22. PubMed ID: 21973303 [TBL] [Abstract][Full Text] [Related]
63. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis. Falagas ME; Kasiakou SK Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582 [TBL] [Abstract][Full Text] [Related]
65. Trends in multidrug-resistant gram-negative bacilli and the role of prolonged β-lactam infusion in the intensive care unit. Guervil DJ; Chau T Crit Care Nurs Q; 2013; 36(4):345-55. PubMed ID: 24002425 [TBL] [Abstract][Full Text] [Related]
67. Multidrug-resistant Gram-negative bacteria: how to treat and for how long. Giamarellou H Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S50-4. PubMed ID: 21129924 [TBL] [Abstract][Full Text] [Related]
68. [Monotherapy vs. combined therapy in the treatment of multi-drug resistance gramnegative bacteria]. Martínez-Sagasti F; González-Gallego MA; Moneo-González A Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():43-6. PubMed ID: 27608313 [TBL] [Abstract][Full Text] [Related]
69. Clinical pharmacokinetics of meropenem in pancreatic juice and site-specific pharmacodynamic target attainment against Gram-negative bacteria: dosing considerations. Kondo N; Ikawa K; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Ohge H; Morikawa N; Sueda T Pancreatology; 2014; 14(2):95-9. PubMed ID: 24650961 [TBL] [Abstract][Full Text] [Related]
70. Antimicrobial consumption and resistance in five Gram-negative bacterial species in a hospital from 2003 to 2011. Lee HS; Loh YX; Lee JJ; Liu CS; Chu C J Microbiol Immunol Infect; 2015 Dec; 48(6):647-54. PubMed ID: 24863496 [TBL] [Abstract][Full Text] [Related]
71. Monitoring Colistin Resistance in Food Animals, An Urgent Threat. Liu Y; Liu JH Expert Rev Anti Infect Ther; 2018 Jun; 16(6):443-446. PubMed ID: 29865881 [No Abstract] [Full Text] [Related]
72. Etiology, extended-spectrum β-lactamase rates and antimicrobial susceptibility of gram-negative bacilli causing intra-abdominal infections in patients in general pediatric and pediatric intensive care units--global data from the Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010. Badal RE; Bouchillon SK; Lob SH; Hackel MA; Hawser SP; Hoban DJ Pediatr Infect Dis J; 2013 Jun; 32(6):636-40. PubMed ID: 23838732 [TBL] [Abstract][Full Text] [Related]
73. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246 [TBL] [Abstract][Full Text] [Related]
74. Development of a miniaturised microarray-based assay for the rapid identification of antimicrobial resistance genes in Gram-negative bacteria. Batchelor M; Hopkins KL; Liebana E; Slickers P; Ehricht R; Mafura M; Aarestrup F; Mevius D; Clifton-Hadley FA; Woodward MJ; Davies RH; Threlfall EJ; Anjum MF Int J Antimicrob Agents; 2008 May; 31(5):440-51. PubMed ID: 18243668 [TBL] [Abstract][Full Text] [Related]
75. Revisiting Beta-lactams - PK/PD improves dosing of old antibiotics. MacGowan A Curr Opin Pharmacol; 2011 Oct; 11(5):470-6. PubMed ID: 21862409 [TBL] [Abstract][Full Text] [Related]
76. Impact of ertapenem on antimicrobial resistance in a sentinel group of Gram-negative bacilli: a 6 year antimicrobial resistance surveillance study. Rodriguez-Osorio CA; Sanchez-Martinez CO; Araujo-Melendez J; Criollo E; Macias-Hernandez AE; Ponce-de-Leon A; Ponce-de-Leon S; Sifuentes-Osornio J J Antimicrob Chemother; 2015 Mar; 70(3):914-21. PubMed ID: 25480492 [TBL] [Abstract][Full Text] [Related]
77. Combination therapy for Gram-negative bacteria: what is the evidence? Kmeid JG; Youssef MM; Kanafani ZA; Kanj SS Expert Rev Anti Infect Ther; 2013 Dec; 11(12):1355-62. PubMed ID: 24168069 [TBL] [Abstract][Full Text] [Related]
78. In vitro activities of antimicrobials against six important species of gram-negative bacteria isolated from raw milk samples in Korea. Nam HM; Lim SK; Kim JM; Joo YS; Jang KC; Jung SC Foodborne Pathog Dis; 2010 Feb; 7(2):221-4. PubMed ID: 19895257 [TBL] [Abstract][Full Text] [Related]
79. What is in the pipeline for Gram-negative pathogens? Talbot GH Expert Rev Anti Infect Ther; 2008 Feb; 6(1):39-49. PubMed ID: 18251663 [TBL] [Abstract][Full Text] [Related]
80. Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China. Guo W; He Q; Wang Z; Wei M; Yang Z; Du Y; Wu C; He J Am J Infect Control; 2015 Apr; 43(4):358-64. PubMed ID: 25838134 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]